Nope, it is not a play on words. When the 1:4 dividend

New Post Public Reply Private Reply Replies (2) Message Board
Zolis_onkel Msowid #14255
385
Nope, it is not a play on words.

When the 1:4 dividend was paid out, I have not received any notice from my brokerage firm that there was a dividend to be paid. So I never received a statement from them nor ANY TYPE of placeholder whatsoever (this does not seem to be too uncommon here in Germany, only a very few have received some sort of placeholder). Related to the most recent 2:5 I have received a letter from the brokerage firm that announced a 2:5 dividend for GNBT shares, no mention whatsoever about the NGIO part of the dividend.
In both cases, ie. the 1:4 a year ago and recently related to the 2:5, I have called the broker and specifically asked for the dividend. First they hadn't heard about the dividend at all, on Wednesday after the pay date, but during the next day, I received the 40% extra GNBT shares into my account. Asking about NGIO, they never heard of it and - as stated in the previous message - they promised to investigate, and a couple of days later wrote me an email telling me that there was no mention about it officially. I then sent them links to related PRs from GNBT and they replied that such information has no value for them. The type of information they need to receive is from the official resource (I guess they meant the trading agent). Besides, they said as long as they do not receive shares, they have nothing that they can actually re-distribute to me. After having exchange many messages back and forth with them, I have decided to leave it until NGIO will finally be publically traded, and if at that time I have still not received anything that looks like NGIO shares, I will be stepping on the broker's toes again, until they have delivered to me what I deserve to receive.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 22

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 15

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 19

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 24

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 11

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 23

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Excitement Builds for the 2025 Special Olympics Winter Games

Updated Category News Views 612

The Opening Ceremony of the 2025 Special Olympics World Winter Games In a grand celebration last night, the lights illuminated the Inalpi Arena, marking the commencement of the 2025 Special Olympics World Winter Games in Turin. This event is poised to become the largest sports and humanitarian gathering of the year. With the lighting of the "Flame of Hope," over 1,500...

Continue Reading
Embracing Pet Ownership: Older Canadians Thrive with Pets

Updated Category News Views 173

Discover the Joy of Pet Ownership Among Older Canadians Pet ownership can transform lives, and for older Canadians, the companionship of a furry friend offers numerous emotional and physical benefits. According to a recent survey by Ipsos for HomeEquity Bank, it has become evident that many Canadians aged 55 and over understand the significant value of sharing their lives...

Continue Reading
Salus Scientific: A Solid Stand Against Industry Recalls Risk

Updated Category News Views 283

Reputation on the Line Nothing shakes the confidence of hospitals like a recall. You know how it is—one day, everything's rolling along fine, and then BAM, safety issues pop up like bad news at a family dinner. Take Salus Scientific, for instance. They’re standing firm against the wave of issues unraveling other companies in radiation protection gear. They’ve got a...

Continue Reading
Investigation into Potential Violations of Securities Laws

Updated Category News Views 276

Investigation into Potential Violations of Securities Laws Halper Sadeh LLC, a dedicated investor rights law firm, has launched an investigation into several companies regarding potential breaches of fiduciary duties and violations of federal securities laws. This initiative particularly aims to benefit shareholders of Old Point Financial Corporation, ProAssurance...

Continue Reading
Concerns Rise Over Fluoride in Children's Oral Products

Updated Category News Views 150

Lawsuits Target Leading Oral Health Brands Recent legal troubles have emerged for Procter & Gamble and Colgate-Palmolive regarding their children's oral care products. Parents are voicing their concerns through multiple lawsuits against these industry giants, claiming that fluoride in toothpaste and mouth rinses poses health risks for young children. Key Products Under...

Continue Reading